ma420 - "The business has never been in a better position" , the...

ma420 - "The business has never been in a better position" , the company and long-term investors know this. Once OSA trial commences, we will have 3 clinical programs underway & a growing market share of the oils distribution market in Australia. The SP will rise as constant news flows. New investors will be entering and existing holders wont be selling. Supply & demand means a sharp rise on any news from expiry date on wards. The company is warming the marketing engines up and soon we will be in the spotlights. It wont be long and we will be at my true current valuation of 40c. ((by this time, my valuation will most likely be a lot more)).